BioSpace News Archive

Pharm Country

COVID-19 patients with cardiovascular disease more likely to develop blood clots post-hospital discharge, Feinstein Institutes study

To better explain the prevalence and cause of clots, researchers from The Feinstein Institutes for Medical Research investigated the rates of clotting 90 days after patients leave the hospital.

May 23, 2023
·
4 min read
Drug Development

Curium Announces Last Patient Enrolled in Their Phase 1/2 SOLAR Clinical Trial Imaging Men with Histologically-Proven Metastatic Prostate Cancer Using Copper Cu 64 PSMA I&T.

Curium, a world leader in nuclear medicine, announced today that it has completed enrollment in its USA-led SOLAR Phase 1/2 study evaluating the safety, biodistribution, and image quality of Copper Cu64 PSMA I&T injection to detect metastatic prostate cancer in PET imaging.

May 23, 2023
·
2 min read
Genetown

Waters Corporation to Present at the Jefferies 2023 Healthcare Conference

Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time.

May 23, 2023
·
1 min read
Genetown

Quest’s Chicagoland Laboratory Hosts Americares Leaders During Lab Week

Quest Diagnostics is proud to support Americares in their efforts to improve health for people affected by poverty or disaster with a grant from Quest for Health Equity.

May 23, 2023
·
2 min read
Business

Ayala Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Corporate Update

Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced first-quarter 2023 financial results and provided a corporate update.

May 23, 2023
·
9 min read
Business

Ivy Brain Tumor Center Builds On Innovative Clinical Trial Program by Appointing New Chief Medical OfficerLeading Neuro-Oncologist Yoshie Umemura, MD, Joins Barrow Neurological Institute

The Ivy Brain Tumor Center and Barrow Neurological Institute are pleased to announce the addition of Yoshie Umemura, MD, as the new Chief Medical Officer of the Ivy Brain Tumor Center and Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute.

May 23, 2023
·
4 min read
Business

Merck Announces Third-Quarter 2023 Dividend

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.73 per share of the company’s common stock for the third quarter of 2023.

May 23, 2023
·
3 min read
Pharm Country

Braeburn’s BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection (CIII) Receives FDA Approval for Moderate to Severe Opioid Use Disorder

Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved BRIXADI (buprenorphine) extended-release injection for subcutaneous use (CIII), a new weekly and monthly medication for moderate to severe opioid use disorder (OUD).

May 23, 2023
·
12 min read
Business

Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update

Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported first quarter 2023 financial results and provided a corporate update.

May 23, 2023
·
10 min read
Pharm Country

Ocugen, Inc. Announces Proposed Public Offering of Common Stock - May 23, 2023

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, announced that it has commenced an underwritten public offering of its common stock.

May 23, 2023
·
3 min read